Posts Tagged ‘FDLI’

FDLI Conference on REMS: Benefits and Risks Meet Liabilities and Opportunities

Wednesday, February 24th, 2010

- Guest blog by Roger Morris, The LondonBritian Company -

You’ve heard all the analogies:  Is the glass half empty or half full?  Does the dark storm cloud have a silver lining?

I was constantly reminded of this during the Food & Drug Law Institute’s latest conference on REMS held February 16 in Washington, D.C., as the residents and transportation system was trying to dig out of one-two snowstorms.  It was an interesting conference, one that built substantially on the groundwork done at last year’s REMS conference which the FDLI co-hosted with ParagonRx. (more…)

Tags: , , , , , , , , , , ,
Posted in Pharmaceuticals, REMS | No Comments »

Are You Attending the FDLI’s Important REMS Conference in Washington?

Friday, February 5th, 2010

- Guest blog by  Roger Morris, The LondonBritain Company -

Having worked in communications in the pharmaceutical industry for more than 25 years, I continue to be amazed at how even strong competitors remain so open to sharing information and experiences.  Perhaps it’s the academic nature of pharmaceutical research that filters out to everyone else in the business, but the industry is constantly talking within itself - from scientific publications about new compounds to physician disease-state annual meetings to specialty conferences.

(more…)

Tags: , , , , , ,
Posted in Pharmaceuticals, REMS | No Comments »